Sunshine Biopharma Inc. Stock Issued During Period, Shares, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Sunshine Biopharma Inc. stock issued during period, shares, other for the quarter ending 2021-03-31 was 58.59M shares.
- Sunshine Biopharma Inc. stock issued during period, shares, other for the quarter ending 2020-12-31 was -267.54M shares.
- Sunshine Biopharma Inc. stock issued during period, shares, other for the quarter ending 2020-09-30 was 34.60M shares.
- Sunshine Biopharma Inc. stock issued during period, shares, other for the quarter ending 2020-06-30 was 210.15M shares.
- Sunshine Biopharma Inc. stock issued during period, shares, other for fiscal 2021 was 559.14K shares, a 64.05% decline from fiscal 2020.
- Sunshine Biopharma Inc. stock issued during period, shares, other for fiscal 2020 was 1.56M shares.
| Period end | Stock Issued During Period, Shares, Other 3 month | Stock Issued During Period, Shares, Other 12 month |
|---|---|---|
| 2021-12-31 | 559.14K shares 10-K · filed 2022-03-21 | |
| 2021-03-31 | 58.59M shares 10-Q · filed 2021-05-11 | 35.79M shares derived: sum of 4 quarters · filed 2022-03-21 |
| 2020-12-31 | -267.54M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | 1.56M shares 10-K · filed 2022-03-21 |
| 2020-09-30 | 34.60M shares derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-12 | |
| 2020-06-30 | 210.15M shares 10-Q/A · filed 2020-08-31 | |
| 2018-09-30 | 646.89M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-16 | |
| 2018-06-30 | -9.28M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-17 | |
| 2018-03-31 | 29.28M shares 10-Q · filed 2018-05-22 | |
| 2017-09-30 | 50.14M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-15 | |
| 2017-06-30 | 50.77M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | |
| 2017-03-31 | 48.43M shares 10-Q · filed 2017-05-12 | |
| 2016-09-30 | 361.59M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | |
| 2016-06-30 | 41.56M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-16 | |
| 2016-03-31 | 34.61M shares 10-Q · filed 2016-05-09 | |
| 2015-09-30 | 7.92M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |